Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-04-001291
Filing Date
2004-03-15
Accepted
2004-03-15 14:16:13
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES INC. b49297tte10vk.htm 10-K 832012
3 EX-10.42 AGREEMENT DATED MAY 1, 2003 b49297ttexv10w42.txt EX-10.42 4771
4 EX-21.1 SUBSIDIARIES b49297ttexv21w1.txt EX-21.1 476
5 EX-23.1 CONSENT OF ERNST & YOUNG LLP b49297ttexv23w1.txt EX-23.1 695
6 EX-31.1 CERTIFICATION OF CEO b49297ttexv31w1.txt EX-31.1 3699
7 EX-31.2 CERTIFICATION OF CFO b49297ttexv31w2.txt EX-31.2 3745
8 EX-32.1 CERTIFICATION PURSUANT TO SEC 906 - CEO b49297ttexv32w1.txt EX-32.1 1343
9 EX-32.2 CERTIFICATION PURSUANT TO SEC 906 - CFO b49297ttexv32w2.txt EX-32.2 1407
  Complete submission text file 0000950135-04-001291.txt   850552
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

EIN.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21481 | Film No.: 04668911
SIC: 2836 Biological Products, (No Diagnostic Substances)